RFG Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.08M | Buy |
14,031
+399
| +3% | +$137K | 0.08% | 171 |
|
|
2026
Q1 | $4.8M | Buy |
13,632
+1,131
| +9% | +$403K | 0.09% | 170 |
|
|
2025
Q4 | $4.09M | Sell |
12,501
-137
| -1% | -$43.5K | 0.08% | 190 |
|
|
2025
Q3 | $3.57M | Buy |
12,638
+462
| +4% | +$134K | 0.07% | 198 |
|
|
2025
Q2 | $3.4M | Buy |
12,176
+1,047
| +9% | +$297K | 0.08% | 196 |
|
|
2025
Q1 | $3.47M | Buy |
11,129
+788
| +8% | +$233K | 0.09% | 156 |
|
|
2024
Q4 | $2.7M | Sell |
10,341
-489
| -5% | -$145K | 0.08% | 200 |
|
|
2024
Q3 | $3.49M | Sell |
10,830
-223
| -2% | -$72.9K | 0.11% | 152 |
|
|
2024
Q2 | $3.45M | Buy |
11,053
+282
| +3% | +$82.8K | 0.11% | 150 |
|
|
2024
Q1 | $3.06M | Sell |
10,771
-417
| -4% | -$122K | 0.1% | 152 |
|
|
2023
Q4 | $3.22M | Sell |
11,188
-537
| -5% | -$146K | 0.13% | 133 |
|
|
2023
Q3 | $3.15M | Buy |
11,725
+408
| +4% | +$102K | 0.14% | 116 |
|
|
2023
Q2 | $2.51M | Buy |
11,317
+478
| +4% | +$111K | 0.11% | 136 |
|
|
2023
Q1 | $2.62M | Sell |
10,839
-380
| -3% | -$93.3K | 0.13% | 127 |
|
|
2022
Q4 | $2.75M | Buy |
11,219
+34
| +0.3% | +$9.11K | 0.14% | 117 |
|
|
2022
Q3 | $3.27M | Buy |
11,185
+318
| +3% | +$77.1K | 0.19% | 104 |
|
|
2022
Q2 | $2.68M | Buy |
10,867
+105
| +1% | +$25.7K | 0.15% | 109 |
|
|
2022
Q1 | $2.6M | Buy |
10,762
+1,612
| +18% | +$370K | 0.17% | 86 |
|
|
2021
Q4 | $2.06M | Buy |
9,150
+331
| +4% | +$69.9K | 0.14% | 98 |
|
|
2021
Q3 | $1.88M | Buy |
8,819
+501
| +6% | +$115K | 0.15% | 103 |
|
|
2021
Q2 | $2.03M | Buy |
8,318
+25
| +0.3% | +$6.15K | 0.18% | 93 |
|
|
2021
Q1 | $2.06M | Sell |
8,293
-21
| -0.3% | -$5.01K | 0.22% | 77 |
|
|
2020
Q4 | $1.98M | Sell |
8,314
-1,540
| -16% | -$355K | 0.26% | 79 |
|
|
2020
Q3 | $2.5M | Sell |
9,854
-993
| -9% | -$246K | 0.35% | 60 |
|
|
2020
Q2 | $2.56M | Buy |
10,847
+599
| +6% | +$137K | 0.4% | 49 |
|
|
2020
Q1 | $2.08M | Buy |
10,248
+528
| +5% | +$115K | 0.39% | 52 |
|
|
2019
Q4 | $2.34M | Buy |
9,720
+3,356
| +53% | +$740K | 0.4% | 52 |
|
|
2019
Q3 | $1.23M | Buy |
6,364
+439
| +7% | +$84.3K | 0.25% | 80 |
|
|
2019
Q2 | $1.09M | Buy |
5,925
+265
| +5% | +$47.5K | 0.25% | 81 |
|
|
2019
Q1 | $1.08M | Sell |
5,660
-209
| -4% | -$39.9K | 0.27% | 77 |
|
|
2018
Q4 | $1.14M | Sell |
5,869
-423
| -7% | -$82.5K | 0.28% | 60 |
|
|
2018
Q3 | $1.3M | Buy |
6,292
+672
| +12% | +$132K | 0.34% | 65 |
|
|
2018
Q2 | $1.04M | Buy |
5,620
+954
| +20% | +$169K | 0.31% | 57 |
|
|
2018
Q1 | $795K | Sell |
4,666
-33
| -0.7% | -$6.06K | 0.3% | 58 |
|
|
2017
Q4 | $847K | Buy |
4,699
+35
| +0.8% | +$6.19K | 0.4% | 61 |
|
|
2017
Q3 | $865K | Sell |
4,664
-71
| -1% | -$12.6K | 0.53% | 34 |
|
|
2017
Q2 | $815K | Buy |
4,735
+2,412
| +104% | +$392K | 0.56% | 35 |
|
|
2017
Q1 | $377K | Sell |
2,323
-84
| -3% | -$14K | 0.28% | 80 |
|
|
2016
Q4 | $403K | Hold |
2,407
| – | – | 0.38% | 56 |
|
|
2016
Q3 | $404K | Sell |
2,407
-44
| -2% | -$7.44K | 0.37% | 57 |
|
|
2016
Q2 | $373K | Buy |
+2,451
| New | +$381K | 0.32% | 62 |
|
Other funds holding AMGN
RFG Advisory's AMGN Position: Q2 2026 in Review
RFG Advisory increased its Amgen (AMGN) stake by 2.9% in Q2 2026, buying an estimated $137K and bringing the position to 14,031 shares worth $5.08M. The position accounts for 0.08% of the portfolio, ranked #171.
RFG Advisory first reported a position in AMGN in Q2 2016 and has held it in 41 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- RFG Advisory held 14,031 shares of Amgen worth $5.08M as of Q2 2026.
- RFG Advisory bought 399 Amgen shares in Q2 2026, an estimated $137K.
- Amgen made up 0.08% of RFG Advisory's portfolio in Q2 2026, its #171 holding.
- RFG Advisory first reported a position in Amgen in Q2 2016 and has held it in 41 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.